Cargando…
Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir
Mutations continue to accumulate within the SARS-CoV-2 genome, and the ongoing epidemic has shown no signs of ending. It is critical to predict problematic mutations that may arise in clinical environments and assess their properties in advance to quickly implement countermeasures against future var...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089321/ https://www.ncbi.nlm.nih.gov/pubmed/36972312 http://dx.doi.org/10.1371/journal.ppat.1011231 |
_version_ | 1785022741100888064 |
---|---|
author | Torii, Shiho Kim, Kwang Su Koseki, Jun Suzuki, Rigel Iwanami, Shoya Fujita, Yasuhisa Jeong, Yong Dam Ito, Jumpei Asakura, Hiroyuki Nagashima, Mami Sadamasu, Kenji Yoshimura, Kazuhisa Sato, Kei Matsuura, Yoshiharu Shimamura, Teppei Iwami, Shingo Fukuhara, Takasuke |
author_facet | Torii, Shiho Kim, Kwang Su Koseki, Jun Suzuki, Rigel Iwanami, Shoya Fujita, Yasuhisa Jeong, Yong Dam Ito, Jumpei Asakura, Hiroyuki Nagashima, Mami Sadamasu, Kenji Yoshimura, Kazuhisa Sato, Kei Matsuura, Yoshiharu Shimamura, Teppei Iwami, Shingo Fukuhara, Takasuke |
author_sort | Torii, Shiho |
collection | PubMed |
description | Mutations continue to accumulate within the SARS-CoV-2 genome, and the ongoing epidemic has shown no signs of ending. It is critical to predict problematic mutations that may arise in clinical environments and assess their properties in advance to quickly implement countermeasures against future variant infections. In this study, we identified mutations resistant to remdesivir, which is widely administered to SARS-CoV-2-infected patients, and discuss the cause of resistance. First, we simultaneously constructed eight recombinant viruses carrying the mutations detected in in vitro serial passages of SARS-CoV-2 in the presence of remdesivir. We confirmed that all the mutant viruses didn’t gain the virus production efficiency without remdesivir treatment. Time course analyses of cellular virus infections showed significantly higher infectious titers and infection rates in mutant viruses than wild type virus under treatment with remdesivir. Next, we developed a mathematical model in consideration of the changing dynamic of cells infected with mutant viruses with distinct propagation properties and defined that mutations detected in in vitro passages canceled the antiviral activities of remdesivir without raising virus production capacity. Finally, molecular dynamics simulations of the NSP12 protein of SARS-CoV-2 revealed that the molecular vibration around the RNA-binding site was increased by the introduction of mutations on NSP12. Taken together, we identified multiple mutations that affected the flexibility of the RNA binding site and decreased the antiviral activity of remdesivir. Our new insights will contribute to developing further antiviral measures against SARS-CoV-2 infection. |
format | Online Article Text |
id | pubmed-10089321 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100893212023-04-12 Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir Torii, Shiho Kim, Kwang Su Koseki, Jun Suzuki, Rigel Iwanami, Shoya Fujita, Yasuhisa Jeong, Yong Dam Ito, Jumpei Asakura, Hiroyuki Nagashima, Mami Sadamasu, Kenji Yoshimura, Kazuhisa Sato, Kei Matsuura, Yoshiharu Shimamura, Teppei Iwami, Shingo Fukuhara, Takasuke PLoS Pathog Research Article Mutations continue to accumulate within the SARS-CoV-2 genome, and the ongoing epidemic has shown no signs of ending. It is critical to predict problematic mutations that may arise in clinical environments and assess their properties in advance to quickly implement countermeasures against future variant infections. In this study, we identified mutations resistant to remdesivir, which is widely administered to SARS-CoV-2-infected patients, and discuss the cause of resistance. First, we simultaneously constructed eight recombinant viruses carrying the mutations detected in in vitro serial passages of SARS-CoV-2 in the presence of remdesivir. We confirmed that all the mutant viruses didn’t gain the virus production efficiency without remdesivir treatment. Time course analyses of cellular virus infections showed significantly higher infectious titers and infection rates in mutant viruses than wild type virus under treatment with remdesivir. Next, we developed a mathematical model in consideration of the changing dynamic of cells infected with mutant viruses with distinct propagation properties and defined that mutations detected in in vitro passages canceled the antiviral activities of remdesivir without raising virus production capacity. Finally, molecular dynamics simulations of the NSP12 protein of SARS-CoV-2 revealed that the molecular vibration around the RNA-binding site was increased by the introduction of mutations on NSP12. Taken together, we identified multiple mutations that affected the flexibility of the RNA binding site and decreased the antiviral activity of remdesivir. Our new insights will contribute to developing further antiviral measures against SARS-CoV-2 infection. Public Library of Science 2023-03-27 /pmc/articles/PMC10089321/ /pubmed/36972312 http://dx.doi.org/10.1371/journal.ppat.1011231 Text en © 2023 Torii et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Torii, Shiho Kim, Kwang Su Koseki, Jun Suzuki, Rigel Iwanami, Shoya Fujita, Yasuhisa Jeong, Yong Dam Ito, Jumpei Asakura, Hiroyuki Nagashima, Mami Sadamasu, Kenji Yoshimura, Kazuhisa Sato, Kei Matsuura, Yoshiharu Shimamura, Teppei Iwami, Shingo Fukuhara, Takasuke Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title | Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title_full | Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title_fullStr | Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title_full_unstemmed | Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title_short | Increased flexibility of the SARS-CoV-2 RNA-binding site causes resistance to remdesivir |
title_sort | increased flexibility of the sars-cov-2 rna-binding site causes resistance to remdesivir |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089321/ https://www.ncbi.nlm.nih.gov/pubmed/36972312 http://dx.doi.org/10.1371/journal.ppat.1011231 |
work_keys_str_mv | AT toriishiho increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT kimkwangsu increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT kosekijun increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT suzukirigel increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT iwanamishoya increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT fujitayasuhisa increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT jeongyongdam increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT itojumpei increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT asakurahiroyuki increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT nagashimamami increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT sadamasukenji increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT yoshimurakazuhisa increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT satokei increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT matsuurayoshiharu increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT shimamurateppei increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT iwamishingo increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir AT fukuharatakasuke increasedflexibilityofthesarscov2rnabindingsitecausesresistancetoremdesivir |